What we’re doing.

Genevant Sciences to Present at the Jefferies 2019 Healthcare Conference

BOSTON, MASSACHUSETTS and BASEL, SWITZERLAND – June 3, 2019– Genevant Sciences, a leading biopharmaceutical company focused on the discovery and development of RNA therapeutics utilizing multiple modalities, today announced that Bo Rode Hansen, MBA, PhD, President and Chief Executive Officer, is … Continued


Genevant Appoints Dr. Margrit Schwarz as Chief Scientific Officer and Head of R&D, and Pete Zorn as Chief Operating Officer

Additions bolster Genevant’s leadership position in the RNA therapeutics space with its multiple modality, “pan-RNA” approach BOSTON, MASSACHUSETTS; BURNABY, CANADA; and BASEL, SWITZERLAND – January 7, 2019 – Genevant Sciences, a leading biopharmaceutical company focused on the discovery and development of … Continued


Genevant President & CEO Dr. Bo Rode Hansen to Present at Biotech Showcase 2019

BOSTON, MASSACHUSETTS; BURNABY, CANADA; and BASEL, SWITZERLAND – January 3, 2019 – Genevant Sciences, a leading biopharmaceutical company focused on the discovery, development, and commercialization of a broad range of RNA-based therapeutics across multiple modalities, announced today that its President … Continued


Genevant Appoints Dr. Bo Rode Hansen as President & CEO and Dr. Mark Kay as an Independent Board Member

Key leadership appointments bolster Genevant’s team of world-class RNA experts and strengthen position as the leading company pursuing a multiple modality “pan-RNA” approach Development of in-house and partnered RNA programs on track, with the aim of delivering 5+ product candidates … Continued


BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership in Rare Diseases

Partnership combines Genevant’s industry-leading delivery technology and BioNTech’s cutting-edge mRNA drug discovery platform to develop best-in-class therapeutics BioNTech and Genevant will develop five products for rare diseases with high unmet medical need under the 50/50 co-development and co-commercialization collaboration Collaboration … Continued